Willie Quinn | Chief Financial Officer & Senior Vice President, Corporate Development |
Dayton Misfeldt | Interim Chief Executive Officer |
Judy Fox | Chief Scientific Officer |
Deepali Suri | Vice President, Clinical Operations |
Jim Birchenough | Wells Fargo Securities |
Hartaj Singh | Oppenheimer |
Kenneth Atkins | Cowen and Company |
Welcome to the Sunesis Pharmaceuticals Fourth Quarter and Year End 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions].
As a reminder, today's conference is being recorded.